Personal tools

Coexpression cluster:C3805: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C3805_Mammary_skeletal_Mesenchymal_Osteoblast_Corneal_Pericytes_Fibroblast |id=C3805 }}")
 
No edit summary
Line 2: Line 2:
|full_id=C3805_Mammary_skeletal_Mesenchymal_Osteoblast_Corneal_Pericytes_Fibroblast
|full_id=C3805_Mammary_skeletal_Mesenchymal_Osteoblast_Corneal_Pericytes_Fibroblast
|id=C3805
|id=C3805
|ontology_enrichment_celltype=CL:0000055!3.12e-19!180;CL:0000057!6.06e-10!75;CL:0000183!2.59e-09!59;CL:0000680!3.61e-08!57;CL:0000056!3.61e-08!57;CL:0000355!3.61e-08!57;CL:0000393!4.62e-08!60;CL:0000211!4.62e-08!60;CL:0000187!1.21e-07!54
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000475!5.47e-16!365;UBERON:0000481!6.98e-15!347;UBERON:0003103!4.72e-14!69;UBERON:0000468!6.33e-12!659;UBERON:0000119!5.66e-11!312;UBERON:0000483!3.42e-10!309;UBERON:0000914!3.89e-10!83;UBERON:0002329!3.89e-10!83;UBERON:0003077!3.89e-10!83;UBERON:0003059!3.89e-10!83;UBERON:0007282!3.89e-10!83;UBERON:0009618!3.89e-10!83;UBERON:0007285!3.89e-10!83;UBERON:0002100!4.81e-10!216;UBERON:0000486!1.84e-09!82;UBERON:0005256!2.47e-09!143;UBERON:0001134!7.65e-09!61;UBERON:0002036!7.65e-09!61;UBERON:0003082!7.65e-09!61;UBERON:0002385!1.03e-08!63;UBERON:0001015!1.03e-08!63;UBERON:0000383!1.03e-08!63;UBERON:0004290!1.73e-08!70;UBERON:0000922!2.56e-08!612;UBERON:0007100!8.27e-08!27;UBERON:0003886!3.87e-07!63;UBERON:0006554!4.80e-07!44;UBERON:0001008!5.68e-07!45;UBERON:0000020!8.16e-07!23;UBERON:0002050!8.45e-07!605;UBERON:0005423!8.45e-07!605
}}
}}

Revision as of 14:41, 21 May 2012


Full id: C3805_Mammary_skeletal_Mesenchymal_Osteoblast_Corneal_Pericytes_Fibroblast



Phase1 CAGE Peaks

Hg19::chr19:46916678..46916710,-p3@CCDC8
Hg19::chr19:46916779..46916800,-p4@CCDC8
Hg19::chr19:46916805..46916852,-p1@CCDC8


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Uber Anatomy
Ontology termp-valuen
organism subdivision5.47e-16365
multi-tissue structure6.98e-15347
compound organ4.72e-1469
multi-cellular organism6.33e-12659
cell layer5.66e-11312
epithelium3.42e-10309
somite3.89e-1083
paraxial mesoderm3.89e-1083
presomitic mesoderm3.89e-1083
presumptive segmental plate3.89e-1083
trunk paraxial mesoderm3.89e-1083
presumptive paraxial mesoderm3.89e-1083
trunk4.81e-10216
multilaminar epithelium1.84e-0982
trunk mesenchyme2.47e-09143
skeletal muscle tissue7.65e-0961
striated muscle tissue7.65e-0961
myotome7.65e-0961
muscle tissue1.03e-0863
musculature1.03e-0863
musculature of body1.03e-0863
dermomyotome1.73e-0870
embryo2.56e-08612
primary circulatory organ8.27e-0827
body cavity precursor3.87e-0763
urinary system structure4.80e-0744
renal system5.68e-0745
sense organ8.16e-0723
embryonic structure8.45e-07605
developing anatomical structure8.45e-07605


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.